Publications

1. His M, Gunter MJ, Keski-Rahkonen P, Rinaldi S (2024). Application of metabolomics to epidemiologic studies of breast cancer: new perspectives for etiology and prevention. J Clin Oncol. 42(1):103–15. https://doi.org/10.1200/JCO.22.02754 PMID:37944067
2. Mahamat-Saleh Y, Aune D, Freisling H, Hardikar S, Jaafar R, Rinaldi S, et al. (2024). Association of metabolic obesity phenotypes with risk of overall and site-specific cancers: a systematic review and meta-analysis of cohort studies. Br J Cancer. 131(9):1480–95. https://doi.org/10.1038/s41416-024-02857-7 PMID:39317703
3. Majidi A, Rinaldi S, Biessy C, Vozar B, Truong T, Turzanski Fortner R, et al. (2025). Thyroid hormones and epithelial ovarian cancer risk and survival: results from the European Prospective Investigation into Cancer and Nutrition study. J Natl Cancer Inst. 117(11):2343–51. https://doi.org/10.1093/jnci/djaf222 PMID:40811636
4. Mayén AL, Sabra M, Aglago EK, Perlemuter G, Voican C, Ramos I, et al. (2024). Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study. BMC Med. 22(1):221. https://doi.org/10.1186/s12916-024-03366-3 PMID:38825687
5. Daniel N, Genua F, Jenab M, Mayén AL, Chrysovalantou Chatziioannou A, Keski-Rahkonen P, et al. (2024). The role of the gut microbiome in the development of hepatobiliary cancers. Hepatology. 80(5):1252–69. https://doi.org/10.1097/HEP.0000000000000406 PMID:37055022
6. Berden J, Chimera B, Hanley-Cook GT, Cakmak EK, Vineis P, Nicolas G, et al. (2025). Biodiverse diets present co-benefits for greenhouse gas emissions, land use, mortality rates and nutritional adequacy in Europe. Nat Food. 6(9):857–67. https://doi.org/10.1038/s43016-025-01214-y PMID:40835792
7. Huybrechts I, Chimera B, Hanley-Cook GT, Biessy C, Deschasaux-Tanguy M, Touvier M, et al. (2024). Food biodiversity and gastrointestinal cancer risk in nine European countries: analysis within a prospective cohort study. Eur J Cancer. 210:114258. https://doi.org/10.1016/j.ejca.2024.114258 PMID:39168001
8. Stein MJ, Freisling H, Leitzmann MF (2025). Clinical obesity and all-cause and cause-specific mortality in UK Biobank. JAMA Intern Med. 185(12):1497–500. https://doi.org/10.1001/jamainternmed.2025.4978 PMID:41143828
9. Córdova R, Kim J, Thompson AS, Noh H, Shah S, Dahm CC, et al. (2025). Plant-based dietary patterns and age-specific risk of multimorbidity of cancer and cardiometabolic diseases: a prospective analysis. Lancet Healthy Longev. 6(8):100742. https://doi.org/10.1016/j.lanhl.2025.100742 PMID:40845891
10. Cordova R, Viallon V, Fontvieille E, Peruchet-Noray L, Jansana A, Wagner KH, et al. (2023). Consumption of ultra-processed foods and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. Lancet Reg Health Eur. 35:100771. https://doi.org/10.1016/j.lanepe.2023.100771 PMID:38115963
11. Breeur M, Atkins J, Peruchet-Noray L, et al. (2026). Autoencoders reveal polyunsaturated fatty acids (PUFA)-related metabolic signature linked to cancer risk. EBioMedicine. (Forthcoming)
12. Gan Q, Freisling H, Peruchet-Noray L, Fontvieille E, Matta K, Zhai Y, et al. (2025). Adiposity, mortality, and disease risk: insights from bioimpedance analysis and magnetic resonance imaging. BMC Med. 23(1):550. https://doi.org/10.1186/s12916-025-04356-9 PMID:41074136
13. Ebrahimi E, Naudin S, Dimou N, Mayén AL, Wang M, Abnet CC, et al. (2025). Alcohol consumption and upper aerodigestive tract squamous cell carcinoma: evidence from 28 prospective cohorts. J Natl Cancer Inst. 117(12):2598–611. https://doi.org/10.1093/jnci/djaf230 PMID:40977057
14. Matta K, Viallon V, Chatziioannou AC, Robinot N, Wedekind R, Dahm CC, et al. (2025). Can serum metabolic signatures inform on the relationship between healthy lifestyle and colon cancer risk? Cancer Metab. 13(1):30. https://doi.org/10.1186/s40170-025-00388-0 PMID:40524238